Epigallocatechin-3-gallate (EGCG) inhibits the migratory behavior of tumor bronchial epithelial cells
<p>Abstract</p> <p>Background</p> <p>Many studies associated the main polyphenolic constituent of green tea, (-)-Epigallocatechin-3-gallate (EGCG), with inhibition of cancers, invasion and metastasis. To date, most of the studies have focused on the effect of EGCG on ce...
Main Authors: | Terryn Christine, Milliot Magali, Nawrocki-Raby Béatrice, Bonnomet Arnaud, Hazgui Salma, Cutrona Jérôme, Polette Myriam, Birembaut Philippe, Zahm Jean-Marie |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2008-04-01
|
Series: | Respiratory Research |
Online Access: | http://respiratory-research.com/content/9/1/33 |
Similar Items
-
Characterization of the Synergistic Antioxidant Activity of Epigallocatechin Gallate (EGCG) and Kaempferol
by: Qiang Zhang, et al.
Published: (2023-07-01) -
Mechanism of (−)-epigallocatechin gallate (EGCG) dimerization by low-temperature plasma
by: Seungil Park, et al.
Published: (2022-09-01) -
Antioxidant and antiviral activities of lipophilic epigallocatechin gallate (EGCG) derivatives
by: Ying Zhong, et al.
Published: (2012-01-01) -
Screening of epigallocatechin-3-gallate (EGCG) content in camellia sinensis products
by: Amran, Syazwani Itri, et al.
Published: (2018) -
Assessing the Hepatic Safety of Epigallocatechin Gallate (EGCG) in Reproductive-Aged Women
by: Hiba Siblini, et al.
Published: (2023-01-01)